RE: [BIONT-DSE] Clinical Observations Interoperability Telcon September 11th, Tuesday 11:00am - 12:00pm US EDT

Dear Rachel and Landen,

 

Following up from the Clinical Observations Interoperability Telcon two weeks ago, I do think your presentations where very interesting. From my perspective working in early clinical development within AstraZeneca I do think  <http://esw.w3.org/topic/HCLS/OntologyTaskForce/BIONTDSEDCM?action=AttachFile&do=get&target=W3C-BIONTDSEDCM-08-28-07.ppt> Landen's slide 10  (secondary use) point out where why we all have a common interest to get the interoperability in place.

 

I like your proposal Rachel to use patient recruitment as use case for this activity. Patient recruitment is a major challenge for us and I guess most pharma companies. It fits well with the future desire to get a better "Real Life" picture of our health care environment. With better information at hand we would understand patient requirements, diseases, etc. much better. This understanding are important for health care providers, pharma companies, health organizations, disease registries, safety organizations etc.

 

Slide 10 represents in my mind this desire for a "Real Life" picture. To achieve this objective data interoperability is only one challenge of many, however if we in this activity can show how semantic web technologies have the potential to solve the interoperability issue, we will create good conditions for this to become a reality!

 

AstraZeneca participate in "Electronic Medical Record Task Force 2007 - EU region", a joint effort by European Federation of Pharmaceutical Industries and Associations (EFPIA) and EC. Within this task force the EHR are discussed in the context of enhancing clinical research for better health and high quality healthcare, i.e. well in line with slide 10.

 

In other words, I support Rachel's proposal and suggest we keep the bigger picture presented by Landen in mind. 

 

Regards,

Bosse

_______________________________________________________ 
Bo Andersson 
Senior Informatician 
Discovery Medicine 
AstraZeneca R&D Lund, S-221 87 Lund, Sweden 
Tel: +46 46 33 76 21 Mobile: +46 709 13 16 21
Fax: +46 46 33 71 92 
E-mail: bo.h.andersson@astrazeneca.com 

-----Original Message-----
From: public-hcls-dse-request@w3.org [mailto:public-hcls-dse-request@w3.org]On Behalf Of Kashyap, Vipul
Sent: 7 september 2007 16:03
To: public-semweb-lifesci@w3.org; public-hcls-dse@w3.org
Cc: Stanley Huff; Yan Heras; Oniki, Tom (GE Healthcare, consultant); Joey Coyle; Landen Bain; Bron W. Kisler
Subject: [BIONT-DSE] Clinical Observations Interoperability Telcon September 11th, Tuesday 11:00am - 12:00pm US EDT



Clinical Observations Interoperability Telcon

 

http://esw.w3.org/topic/HCLS/OntologyTaskForce/BIONTDSEDCM

 

Date and Time:

Spetember 11th, Tuesday 11:00am - 12:00pm EDT

 

Agenda

Discussion and Finalization of Use Case

 

Telcon Details:

 


Phone

+1 617 761 6200, conference 24668 ("BIONT")


IRC

irc://irc.w3.org:6665/hcls


Browser-based IRC client

http://www.w3.org/2001/01/cgi-irc

 

 

Feel free to annotate wiki page above with feedback and suggestions.

 

Cheers,

 

---Vipul

 

=======================================

Vipul Kashyap, Ph.D.

Senior Medical Informatician

Clinical Informatics R&D, Partners HealthCare System

Phone: (781)416-9254

Cell: (617)943-7120

http://www.partners.org/cird/AboutUs.asp?cBox=Staff <http://www.partners.org/cird/AboutUs.asp?cBox=Staff&stAb=vik> &stAb=vik

 

To keep up you need the right answers; to get ahead you need the right questions

---John Browning and Spencer Reiss, Wired 6.04.95



The information transmitted in this electronic communication is intended only for the person or entity to whom it is addressed and may contain confidential and/or privileged material. Any review, retransmission, dissemination or other use of or taking of any action in reliance upon this information by persons or entities other than the intended recipient is prohibited. If you received this information in error, please contact the Compliance HelpLine at 800-856-1983 and properly dispose of this information.